AbbVie (ABBV) Enterprise Value (2013 - 2026)
AbbVie's Enterprise Value was $452 billion in Q3 2026, up 12.0% from $403.59 billion a year earlier and up 3.2% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Enterprise Value (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, AbbVie's Enterprise Value was $430.78 billion through Sep 30, 2026, up 11.5% year-over-year; for FY2025, it was $398.79 billion, up 29.4% from FY2024.
- Enterprise Value shows a five-year compound annual growth rate of 17.1% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $308.19 billion in FY2024 (+18.1%), $260.97 billion in FY2023 (-5.7%), $276.76 billion in FY2022 (+20.5%) and $229.69 billion in FY2021 (+27.1%).
- The Q3 2026 figure marks the highest quarterly Enterprise Value in data going back to Q1 2013.
- Compared with a year earlier, Enterprise Value has increased for 11 straight quarters, with growth averaging 18.5% over the last eight quarters.
- The best year-over-year quarter for Enterprise Value over five years was Q1 2022 (growth of 53.8%); the worst was Q2 2023 (a decline of 12.2%).
- Per Business Quant data, ABBV's Enterprise Value in the three quarters before Q3 2026 was $438.16 billion (Q2 2026), $374.91 billion (Q1 2026) and $398.79 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 452.00 Bn |
| Jun 30, 2026 | 438.16 Bn |
| Mar 31, 2026 | 374.91 Bn |
| Dec 31, 2025 | 398.79 Bn |
| Sep 30, 2025 | 403.59 Bn |
| Jun 30, 2025 | 321.49 Bn |
| Mar 31, 2025 | 364.96 Bn |
| Dec 31, 2024 | 308.19 Bn |
| Sep 30, 2024 | 341.73 Bn |
| Jun 30, 2024 | 289.85 Bn |
| Mar 31, 2024 | 303.54 Bn |
| Dec 31, 2023 | 260.97 Bn |
| Sep 30, 2023 | 249.92 Bn |
| Jun 30, 2023 | 229.07 Bn |
| Mar 31, 2023 | 274.48 Bn |
| Dec 31, 2022 | 276.76 Bn |
| Sep 30, 2022 | 225.50 Bn |
| Jun 30, 2022 | 260.88 Bn |
| Mar 31, 2022 | 278.93 Bn |
| Dec 31, 2021 | 229.69 Bn |
API Access
AbbVie Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();